Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.

Item
http://www.wikidata.org/entity/Q30940329
Combination therapy with biologic agents in rheumatic diseases: current and future prospectsBiologics registers in RA: methodological aspects, current role and future applications.Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study.Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study.Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis.Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry.Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases
P2860

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.

Item
http://www.wikidata.org/entity/Q30940329
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@ast
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@en
type
label
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@ast
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@en
prefLabel
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@ast
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Effectiveness of biologic DMAR ...... l Quality Management Registry.
@en
P2093
P2860
P304
P31
P356
10.1093/RHEUMATOLOGY/KEV019
P433
P478
P50
P577
P698